If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

Share Price is delayed by 15 minutes
Get Live Data
11.25    0.00 (0.00%)
Bid:
11.00
Ask:
11.50
Spread: 0.50 (4.545%)
Market Cap: £24.54m
SOS Live PriceLast checked at - London Stock Exchange

Intraday Sosandar Share Chart

Fund raising to accelerate drilling at Mutsk

4 Oct 2013 07:00

RNS Number : 7031P
Orogen Gold PLC
04 October 2013
Β 

ο»Ώ

Β 

Β 

Orogen Gold Plc

("Orogen" or "the Company")

Β 

Placing raising Β£0.65 million to accelerate drill testing of the exciting Mutsk gold project in Armenia

Β 

Orogen (AIM:ORE),Β the AIM quoted gold exploration company,announces that it has conditionally placedΒ 216,666,667 new ordinary sharesΒ ("PlacingΒ Shares")Β ofΒ 0.1p each ("Ordinary Shares") withΒ existing and new investors at a price ofΒ 0.3p per share,Β raisingΒ Β£650,000Β before costs (the "Placing"). The net proceeds of the Placing will provideΒ additional working capital which will be used, inter alia, to accelerate the Company's exploration programmes over its highly prospective Mutsk gold property in Armenia.

Β 

The Placing Shares will represent approximately 9.04 per cent of the Company's enlarged share capital.

Β 

Ed Slowey, Chief Executive of Orogen Gold comments:

Β 

"We have had an excellent start to our drilling campaign at Mutsk with the first shallow drill holes returning higher gold grades than expected near surface over considerable widths. These new funds will provide us with a strong base from which to plan our 2014 work programme, and will also allow us to re-commence drilling during the remainder of this Autumn season. We are pleased with the continuing support of our shareholders and look forward to updating the market with further progress reports and drill results from both Armenia and Serbia over the coming months."

Β 

Β 

Rationale for theΒ Placing

Β 

The net proceeds of the Placing will enable the Company to progress with further drilling at the Mutsk gold project, Armenia, where the Directors are seeking to deliver increased shareholder valueΒ by targeting a maiden resource within 2014. Orogen has an exclusive agreement with JV partner, Georaid CJSC, to earn an 80% interest in the property by spending a total of US$2.5m by the end of August 2016.

Β 

Orogen recently announced highly positive preliminary drilling results from Mutsk, with assay intervals including 11.0m @ 5.56g/t Au and 10.2m @ 5.73g/t Au. The Company has confirmed a mineralised zone over almost 1km of strike, with possible extension to 2km+.

Β 

Β 

Directors' Participation in the Placing

Β 

Each of the Directors has agreed to subscribe for 6,666,667 Placing Shares and their resulting holdings following the Placing will be as follows:

Β 

Director

Shareholding following Placing

% of enlarged share capital

John Barry

127,222,158

5.31

Ed Slowey

126,222,158

5.27

Alan Mooney

89,936,994

3.75

Michael Nolan

89,936,994

3.75

Adam Reynolds

47,366,667

1.98

Β 

Β 

Β 

Issue of the Placing Shares

Β 

TheΒ PlacingΒ isΒ solelyΒ conditional upon admissionΒ of the Placing Shares toΒ AIM ("Admission").

Β 

Application will be made to the London Stock Exchange for theΒ PlacingΒ Shares to be admitted to trading onΒ AIM. It is expected that such Admission will become effective and that dealings will commence onΒ orΒ aroundΒ 24 October 2013.

Β 

TheΒ PlacingΒ Shares will, when issued, rankΒ pari passuΒ in all respects with the existing Ordinary Shares.

Β 

Β 

Total Voting Rights

Β 

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capitalΒ following the completion of the Placing willΒ consistΒ of 2,395,839,120 ordinaryΒ shares of 0.1p each with one voting right per share. There are no shares held in treasury.Β 

Β 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Β 

Enquiries:

Β 

Orogen Gold Plc

+353 1662 8395

Ed Slowey, CEO

Alan Mooney, FD

WH Ireland Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 7220 1666

Tim Feather

James Bavister

XCAP Securities plc (Joint Broker)

+44 (0) 20 7101 7070

Jon Belliss

Walbrook (Public Relations and Investor Relations)

+44 (0) 20 933 8780

Bob Huxford/ Guy McDougall (Public Relations)

Paul Cornelius (Investor Relations)

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAKEDEFFDFFF
Date   Source Headline
25th Jun 20261:53 pmRNSNotice of Results & Investor Presentation
24th Jun 20267:00 amRNSAppointment of Nominated Adviser and Broker
11th Jun 20261:07 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20263:36 pmRNSNotification of major holdings
1st Jun 20263:40 pmRNSTransaction in Own Shares and Total Voting Rights
11th May 20263:27 pmRNSNotification of major holdings
5th May 20268:17 amRNSHolding(s) in Company
1st May 202611:48 amRNSHolding(s) in Company
30th Apr 20261:41 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20269:25 amRNSHolding(s) in Company
21st Apr 20264:30 pmRNSHolding(s) in Company
14th Apr 20267:00 amRNSFull Year Trading Update
1st Apr 202610:31 amRNSResult of General Meeting
25th Mar 202612:00 pmRNSTransaction in Own Shares and Total Voting Rights
13th Mar 20267:00 amRNSNotice of General Meeting
13th Mar 20267:00 amRNSNotice of General Meeting
3rd Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20261:47 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20262:00 pmRNSTransaction in Own Shares and Total Voting Rights
20th Jan 20267:00 amRNSBoard Change
19th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jan 20262:10 pmRNSNotification of major holdings
15th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20267:00 amRNSTrading Update
6th Jan 202612:00 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20252:24 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20252:24 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20257:00 amRNSRestructuring of executive share incentives
12th Dec 20254:49 pmRNSNotification of major holdings
26th Nov 20253:08 pmRNSNotification of major holdings
25th Nov 20257:00 amRNSHalf Year Results
21st Nov 202511:42 amRNSNotification of major holdings
20th Nov 20257:00 amRNSNotification of major holdings
13th Nov 20257:00 amRNSNotification of major holdings
10th Nov 20254:33 pmRNSNotification of Major Holdings
29th Oct 20257:00 amRNSNotice of Results and Investor Presentation
20th Oct 202510:18 amRNSDirector/PDMR Shareholding
20th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20252:03 pmRNSHolding(s) in Company
16th Oct 202511:24 amRNSCapital Reduction - Effective
14th Oct 20254:00 pmRNSCapital Reduction - Court Approval
14th Oct 20257:00 amRNSHalf Year Trading Update
3rd Oct 202512:32 pmRNSHolding(s) in Company
2nd Oct 20255:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.